Bridging Nations. Accelerating Therapies for Rare Diseases Together. The organization’s 2030 vision institutionalizes ...

Human pluripotent stem-cells (HPSCs)—including human embryonic stem-cells and human induced pluripotent stem-cells—are reshaping the landscape of regenerative medicine.1,2 In Parkinson's disease, ...

Academia Sinica and National Taiwan University (NTU) Hospital have jointly developed PanMETAI, an AI metabolomics platform to detect the early stages of pancreatic cancer. The tabular AI model detects ...

For decades, scientists believed a fertilized egg’s DNA began as a shapeless mass, only organizing itself once the embryo switched on its genes. But new research reveals that the genome is already ...

New FDA guidelines for personalized genomic drug development are a step forward in advancing new therapies for ultrarare diseases, but industry leaders need further clarification.

A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...

The human genome is a rich, complex record of migration, encounters, and inheritance written over thousands of millennia.

AGBT today announced the recipients of the 2026 Next Gen Leadership Awards for the AGBT General Meeting. These awards recognize outstanding early-career researchers and graduate students whose work ...

The addition of PacBio to the iHope network will further expand diagnostic access worldwide DAMASCUS, MD, UNITED ...